Filter Options
Required*
Filter
New York / New York / United States
0.0
Myrexis, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer. The company has leveraged a unique understanding of the genetic causes of human disease to generate a strong pipeline of clinical and preclinical product candidates. These include compounds with distinct mechanisms of action and novel chemical structures that have first-in-class and/or best-in-class therapeutic potential. Myrexis is led by an experienced management team with expertise in human genetics, protein-protein interaction technology, chemical proteomic drug discovery and clinical and commercial development.
New York / New York / United States
0.0
New York / New York / United States
0.0
Founded in 1999, AngioGenex is a publicly held biopharmaceutical company that is engaged in the development of applications based on research into Id genes and proteins. It specializes in the discovery of Id-based products for the treatment and diagnosis of cancer and therapeutic care applications. The company additionally develops drugs for diabetes, retinopathy and endometriosis. It provides diagnostic products for oncological conditions and breast, melanoma and cervical cancers. The company specializes in a variety of procedures, such as coronary artery bypass grafting, balloon angioplasty and stent placement. AngioGenex has a partnership with BioCheck for the development and research of diagnostic and treatment products.
New York / New York / United States
0.0
Manhattan Pharmaceuticals is a specialty pharmaceutical development company based in New York City. Manhattan is focused on the licensing and development of specialty pharmaceuticals for major therapeutic areas with medical need, such as obesity. The company s lead compound, oleoyl-estrone, is an orally administered compound for the treatment of obesity that has been shown to cause significant weight loss in preclinical studies. The company is also developing a proprietary lingual spray formulation of Propofol, one of the worlds best-selling general anesthetics, as a sedative-hypnotic prior to diagnostic and therapeutic procedures. The company has partnerships with Indevus Pharmaceuticals for the development of CT-3 for the treatment of pain, and with Bausch & Lomb for Manhattans Avantix cataract removal device. Established in 2001, Manhattan Pharmaceuticals merged with Atlantic Technology Ventures in 2003.
New York / New York / United States
0.0
New York / New York / United States
0.0
New York / New York / United States
0.0
New York / New York / United States
0.0
Atrinsic is one of the leading digital advertising and entertainment networks in the United States. The company offers digital music, casual game and sweepstakes solutions. Its brand, Altnet, is a mobile legal music download service that features original artists. The company provides iMatchUp, which is an integrated Web-mobile dating service. Atrinsic also offers a premium online and mobile gaming site, GatorArcade. The company s marketing division, RocketProfit, serves the publisher community. It provides access to a proprietary network of mobile entertainment sites. In addition, the company offers e-mail marketing solutions, including campaign reporting and creative testing options. It provides search engine marketing and optimization services. Atrinsic is a publicly traded company that offers a low-bid mobile auction game, Bid4Prizes.